These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A. Lancet; 1996 Feb 10; 347(8998):353-7. PubMed ID: 8598700 [Abstract] [Full Text] [Related]
3. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis. Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D. Bone Marrow Transplant; 1999 Sep 10; 24(5):473-81. PubMed ID: 10482930 [Abstract] [Full Text] [Related]
9. Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma. Uyl-de Groot CA, Ossenkoppele GJ, Buijt I, Huijgens PC. Pharmacoeconomics; 1999 Mar 01; 15(3):305-11. PubMed ID: 10537437 [Abstract] [Full Text] [Related]
11. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A. J Clin Oncol; 1994 Oct 01; 12(10):2176-86. PubMed ID: 7523609 [Abstract] [Full Text] [Related]
17. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Pettengell R, Morgenstern GR, Woll PJ, Chang J, Rowlands M, Young R, Radford JA, Scarffe JH, Testa NG, Crowther D. Blood; 1993 Dec 15; 82(12):3770-7. PubMed ID: 7505124 [Abstract] [Full Text] [Related]
18. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Green MD, Rowlings PA, McGrath KM, Cebon J. Bone Marrow Transplant; 1994 Jul 15; 14(1):105-11. PubMed ID: 7524904 [Abstract] [Full Text] [Related]